Therapeutic agents and uses thereof
AssigneeAnkh Life Sciences Limited
InventorsGene H. ZAID, Thomas W. BURGOYNE
Life of this patent
Estimating the term…
Abstract
Methods of treating cancer with human therapeutic compositions are provided, comprising compounds including a plurality of fused polycyclic moieties and a linker moiety. In certain embodiments, the compounds are the reaction products of aldehyde and harmaline components. The compositions exhibit anti-cancer properties, especially against lymphoma, leukemia, pancreatic, endometrial, ovarian, gastric, breast, renal, cervical, head and neck, and myeloma cell lines.
Claims14
A method of treating a human cancer patient comprising the step of administering to the patient an effective amount of a composition comprising a therapeutic compound and optionally another ingredient selected from the group consisting of active agents, preservatives, buffering agents, salts, carriers, excipients, diluents, and other pharmaceutically acceptable ingredients, and combinations thereof, said therapeutic compound having a pair of fused tricyclic moieties bound together by a single linker moiety, where at least one of the rings of each of the fused tricyclic moieties is a N-containing ring, said linker moiety providing bonding branches from a single non-metal atom forming at least a part of the linker moiety, such that said fused tricyclic moieties are bonded to said linker through said single atom, said linker including a methine group, said single non-metal atom being the carbon atom of said methine group.
Dependencies are inferred from the claim text.